Impact of the HIV-1 env Genetic Context outside HR1–HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates

• Franky Baatz,

  Affiliation Laboratory of Retrovirology, CRP-Santé, Luxembourg, Luxembourg

  ⨯
• Monique Nijhuis,

  Affiliation Department of Virology, Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands

  ⨯
• Morgane Lemaire,

  Affiliation Laboratory of Retrovirology, CRP-Santé, Luxembourg, Luxembourg

  ⨯
• Martiene Riedijk,

  Affiliations Department of Virology, Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands, Department of Internal Medicine and Infectious Diseases, UMC Utrecht, Utrecht, The Netherlands

  ⨯
• Annemarie M. J. Wensing,

  Affiliation Department of Virology, Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands

  ⨯
• Jean-Yves Servais,

  Affiliation Laboratory of Retrovirology, CRP-Santé, Luxembourg, Luxembourg

  ⨯
• Petra M. van Ham,

  Affiliation Department of Virology, Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands

  ⨯
• Andy I. M. Hoepelman,

  Affiliation Department of Internal Medicine and Infectious Diseases, UMC Utrecht, Utrecht, The Netherlands

  ⨯
• Peter P. Koopmans,

  Affiliation Division Infectious Diseases, Department of General Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

  ⨯
• Herman G. Sprenger,

  Affiliation Division of Infectious Diseases, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands

  ⨯
• Carole Devaux,

  Affiliation Laboratory of Retrovirology, CRP-Santé, Luxembourg, Luxembourg

  ⨯
• Jean-Claude Schmit,

  Affiliation Laboratory of Retrovirology, CRP-Santé, Luxembourg, Luxembourg

  ⨯
• Danielle Perez Bercoff

  * E-mail: danielle.perezbercoff@crp-sante.lu

  Affiliation Laboratory of Retrovirology, CRP-Santé, Luxembourg, Luxembourg

  ⨯